Weilert, Frank
Waikato Hospital · Waikato District Health Board
2 papers on CoChatORCID 0000-0002-7046-5909
Most cited papers
- Verified
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients: Mitoquinone and liver damage
Gane, E. J., Weilert, F., Orr, D. W., Keogh, G. F., Gibson, M., Lockhart, M. M., Frampton, C. M., Taylor, K. M., Smith, R. A. J., & Murphy, M. P. (2010) · Liver International
Hepatitis C virus researchDrug-Induced Hepatotoxicity and Protection
Cited by 379
- Verified
847 phase II study of the mitochondrial antioxidant mitoquinone for hepatitis C
Gane, E. J., Orr, D. W., Weilert, F., Keogh, G. F., Gibson, M., Murphy, M. P., Smith, R. A., Lockhart, M. M., Frampton, C. M., & Taylor, K. M. (2008) · Journal of Hepatology
Hepatitis C virus researchCoenzyme Q10 studies and effects
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free